GRI
GRI Bio, Inc. - Common Stock (GRI)
$87
About GRI Bio, Inc. - Common Stock (GRI)
GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.
Details
Daily high
$1.89
Daily low
$1.72
Price at open
$1.85
52 Week High
$80.36
52 Week Low
$1.72
Market cap
3.3M
Dividend yield
0.00%
Volume
36,564
Avg. volume
120,545
P/E ratio
-.02
GRI Bio, Inc. - Common Stock News
Details
Daily high
$1.89
Daily low
$1.72
Price at open
$1.85
52 Week High
$80.36
52 Week Low
$1.72
Market cap
3.3M
Dividend yield
0.00%
Volume
36,564
Avg. volume
120,545
P/E ratio
-.02